World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
44
Citations
7225
World Ranking
4790
National Ranking
2148

Phyllis B. Silver publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Phyllis B. Silver sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 155 publications — 18th percentile

18% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Phyllis B. Silver D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Phyllis B. Silver sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 44 D-Index — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Phyllis B. Silver is affiliated with the National Institutes of Health in the United States and has contributed extensively to research in immunology and microbiology, with a strong focus on medicine. Their scholarly output includes work spanning immunology, ophthalmology, molecular biology, rheumatology, and applied microbiology and biotechnology.

The main topics addressed in Silver's research include:

  • Psoriasis: Treatment and Pathogenesis
  • Ocular Diseases and Behçet's Syndrome
  • Mast cells and histamine
  • Immunodeficiency and Autoimmune Disorders
  • Antibiotic Use and Resistance
  • Nosocomial Infections in ICU
  • Antibiotics Pharmacokinetics and Efficacy

Notable recent publications by Silver consist of:

  • The Cytokine IL-17A Limits Th17 Pathogenicity via a Negative Feedback Loop Driven by Autocrine Induction of IL-24, 2020, Immunity
  • Opportunities to Improve Antibiotic Appropriateness in U.S. ICUs: A Multicenter Evaluation, 2020, Critical Care Medicine
  • Autoimmunity to neuroretina in the concurrent absence of IFN-γ and IL-17A is mediated by a GM-CSF-driven eosinophilic inflammation, 2020, Journal of Autoimmunity
  • Draft Reference Genome Sequence of Corynebacterium mastitidis RC, an Ocular Commensal, Isolated from Mouse Conjunctiva, 2022, Microbiology Resource Announcements
  • A novel self-regulatory mechanism of Th17 cells controls autoimmune uveitis through interleukin-24, 2020, The Journal of Immunology

Silver frequently collaborates with a group of researchers, including:

  • Rachel R Caspi
  • Chi-Chao Chan
  • Mary J. Mattapallil
  • So Jin Bing
  • Yingyos Jittayasothorn

The primary journals in which Silver has published multiple works include:

  • The Journal of Immunology
  • Immunity
  • Critical Care Medicine
  • Journal of Autoimmunity
  • Microbiology Resource Announcements

The research focuses on advanced immunological mechanisms, including the role of cytokines like IL-17A and IL-24 in immune regulation and autoimmune pathologies. Silver's work also extends to clinical concerns such as antibiotic stewardship in intensive care units, highlighting intersections between immunology and applied medical practice.

Best Publications

  • Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category.

    Dror Luger;Phyllis B Silver;Jun Tang;Daniel J. Cua

  • Calcitriol Suppresses Antiretinal Autoimmunity through Inhibitory Effects on the Th17 Effector Response

    Jun Tang;Ru Zhou;Dror Luger;Wei Zhu

  • Microbiota-Dependent Activation of an Autoreactive T Cell Receptor Provokes Autoimmunity in an Immunologically Privileged Site

    Reiko Horai;Carlos R. Zárate-Bladés;Patricia Dillenburg-Pilla;Jun Chen;Jun Chen

  • Rodent models of experimental autoimmune uveitis.

    Rajeev K Agarwal;Phyllis B Silver;Rachel R Caspi

  • An Ocular Commensal Protects against Corneal Infection by Driving an Interleukin-17 Response from Mucosal γδ T Cells

    Anthony J. St. Leger;Jigar V. Desai;Rebecca A. Drummond;Abirami Kugadas

  • Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis.

    Teresa K. Tarrant;Phyllis B. Silver;Jennifer L. Wahlsten;Luiz Vicente Rizzo

  • Endogenous systemic IFN-gamma has a protective role against ocular autoimmunity in mice.

    RR Caspi;CC Chan;BG Grubbs;PB Silver

  • Essential Role of the MyD88 Pathway, but Nonessential Roles of TLRs 2, 4, and 9, in the Adjuvant Effect Promoting Th1-Mediated Autoimmunity

    Shao Bo Su;Phyllis B. Silver;Rafael S. Grajewski;Rajeev K. Agarwal

  • Genetic susceptibility to experimental autoimmune uveoretinitis in the rat is associated with an elevated Th1 response.

    R R Caspi;P B Silver;C C Chan;B Sun

  • Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype.

    Dody Avichezer;Phyllis B. Silver;Chi-Chao Chan;Barbara Wiggert

  • The Cytokine IL-17A Limits Th17 Pathogenicity via a Negative Feedback Loop Driven by Autocrine Induction of IL-24.

    Wai Po Chong;Wai Po Chong;Mary J. Mattapallil;Kumarkrishna Raychaudhuri;So Jin Bing

  • Mouse Models of Experimental Autoimmune Uveitis

    Rachel R. Caspi;Phyllis B. Silver;Dror Luger;Jun Tang

  • Endogenous IL-12 Is Required for Induction and Expression of Experimental Autoimmune Uveitis

    Teresa K. Tarrant;Phyllis B. Silver;Chi Chao Chan;Barbara Wiggert

  • Autoimmune Uveitis Elicited with Antigen-Pulsed Dendritic Cells Has a Distinct Clinical Signature and Is Driven by Unique Effector Mechanisms: Initial Encounter with Autoantigen Defines Disease Phenotype

    Jun Tang;Wei Zhu;Phyllis B. Silver;Shao Bo Su

  • The requirement for pertussis to induce EAU is strain-dependent: B10.RIII, but not B10.A mice, develop EAU and Th1 responses to IRBP without pertussis treatment.

    Phyllis B. Silver;Chi-Chao Chan;Barbara Wiggert;Rachel R. Caspi

  • Identification of a major pathogenic epitope in the human IRBP molecule recognized by mice of the H-2r haplotype

    P. B. Silver;L. V. Rizzo;Chi-Chao Chan;L. A. Donoso

  • Anti-tumor necrosis factor alpha therapy suppresses the induction of experimental autoimmune uveoretinitis in mice by inhibiting antigen priming.

    Gil Sartani;Phyllis B. Silver;Luiz V. Rizzo;Chi-Chao Chan

  • Uveitogenicity Is Associated with a Th1-like Lymphokine Profile: Cytokine-Dependent Modulation of Early and Committed Effector T Cells in Experimental Autoimmune Uveitis

    Hui Xu;Luiz V. Rizzo;Phyllis B. Silver;Rachel R. Caspi

  • Endogenous IRBP can be dispensable for generation of natural CD4+CD25+ regulatory T cells that protect from IRBP-induced retinal autoimmunity

    Rafael S. Grajewski;Phyllis B. Silver;Rajeev K. Agarwal;Shao Bo Su

  • Establishment and characterization of a murine CD4+ T cell line and clone that induce experimental autoimmune uveoretinitis in B10.A mice.

    L. V. Rizzo;P. Silver;B. Wiggert;F. Hakim

  • An immunologically privileged retinal antigen elicits tolerance: major role for central selection mechanisms.

    Dody Avichezer;Rafael S. Grajewski;Chi Chao Chan;Mary J. Mattapallil

Frequent Co-Authors

Rachel R. Caspi
Rachel R. Caspi National Institutes of Health
Chi-Chao Chan
Chi-Chao Chan National Institutes of Health
Reiko Horai
Reiko Horai National Eye Institute
Daniel J. Cua
Daniel J. Cua Johnson & Johnson (United States)
Barbara Wiggert
Barbara Wiggert National Institutes of Health
Yoichiro Iwakura
Yoichiro Iwakura Tokyo University of Science
Robert A. Kastelein
Robert A. Kastelein MSD (United States)
Mitchell Kronenberg
Mitchell Kronenberg University of California, San Diego
Michael A. Kaliner
Michael A. Kaliner National Institutes of Health
Ronald L. Wilder
Ronald L. Wilder National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology can open doors to a variety of career pathways, including advanced nursing roles that intersect with immune system research and patient care. For those interested in healthcare, pursuing the easiest nurse practitioner program online offers a streamlined path into clinical practice with flexible learning schedules.

Mental health is closely linked to immunology, and programs like the best online pmhnp programs are highly sought after for their quality clinical placements, preparing graduates to impact psychiatric patient care effectively.

Cost is always a consideration, so exploring the cheapest pmhnp programs can help prospective students find affordable options without compromising on education quality.

Career advancement in nursing often leads to roles that require a Doctor of Nursing Practice (DNP). Understanding the doctor of nursing practice salary by state can help graduates make informed decisions about their career locations and potential earnings in this rewarding field.

Best Scientists Citing Phyllis B. Silver

Trending Scientists